Current Tropical Medicine Reports, published by Springer, is an esteemed journal that serves as a pivotal platform for researchers, professionals, and students in the fields of immunology, allergy, and infectious diseases. With a strong focus on emerging tropical medicine topics, the journal provides an authoritative avenue for disseminating innovative research and practical insights, showcasing its commitment to advancing global health knowledge. Now in its convergence years from 2014 to 2024, it has successfully established itself in the academic community, evidenced by its Q2 rankings in the categories of Infectious Diseases and Immunology and Allergy in 2023, reflecting its impact and relevance. The journal boasts impressive Scopus rankings, holding the 50th position in Infectious Diseases and 55th in Immunology and Allergy, further underscoring its significance in these critical fields. While it operates under a subscription model, the journal serves not only as a resource for published research but also as a catalyst for collaboration and knowledge exchange among the scientific community. With a growing readership, Current Tropical Medicine Reports is poised to continue shaping the discourse surrounding tropical health challenges.

Tropical Medicine & International Health is a distinguished journal published by Wiley, dedicated to the exploration and dissemination of cutting-edge research in the fields of infectious diseases, parasitology, and public health. With a robust open-access option, the journal facilitates the widespread sharing of information critical to addressing health issues in tropical and international settings. Since its inception in 1996, it has established a significant presence in the academic community, as indicated by its impressive ranking in various Scopus categories, notably positioned in the Q1 quartile for Parasitology and Q2 for both Infectious Diseases and Public Health, reflecting its high influence within these domains. The journal's commitment to advancing knowledge on health challenges prevalent in tropical environments makes it an invaluable resource for researchers, healthcare professionals, and students alike who are dedicated to improving global health outcomes.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

Asian Pacific Journal of Tropical Medicine, published by Wolters Kluwer Medknow Publications, stands at the forefront of research in the field of tropical medicine, contributing significantly to the global understanding of health issues prevalent in the Asian Pacific region. With an ISSN of 1995-7645 and an E-ISSN of 2352-4146, this esteemed journal has been an Open Access platform since 2011, ensuring that vital research is accessible to a broad audience. The journal boasts a commendable Scopus rank of 131 out of 636 in the General Medicine category, placing it in the 79th percentile and recognizing its influential contributions to the discipline. Based in Mumbai, India, the journal spans converged years from 2010 to 2024 and is categorized in the Q3 quartile for miscellaneous medicine as of 2023. Researchers, professionals, and students can leverage this journal to stay abreast of the latest findings and developments in tropical medicine, making it an indispensable resource in their academic and professional pursuits.

Health Science Reports is a premier open-access journal published by WILEY, dedicated to advancing knowledge in the diverse field of health sciences. Since its inception in 2018, this journal has provided a vital platform for researchers, professionals, and students to disseminate their work, focusing on a wide array of medical and health-related topics. Recognized for its quality and impact, Health Science Reports has achieved a Q2 ranking in the 2023 category of Medicine (miscellaneous), positioning itself within the 59th percentile of general medicine according to Scopus rankings. The journal aims to bridge the gap between emerging research and practical applications, thereby fostering interdisciplinary collaboration among scientists and practitioners. As an open-access publication, it ensures that cutting-edge research is freely accessible to a global audience, enhancing the visibility of contributions in this critical area of study. With its commitment to rigorous peer review and scholarly excellence, Health Science Reports is poised to become an essential resource for anyone involved in health sciences.

The Japanese Journal of Infectious Diseases, published by the National Institute of Infectious Diseases in Japan, serves as a vital platform for researchers, clinicians, and public health professionals committed to advancing the field of infectious disease science. With an ISSN of 1344-6304 and an E-ISSN of 1884-2836, this journal has maintained its academic rigor since its inception in 1961 and continues to contribute significantly to the global understanding of infectious diseases. The journal holds a Q3 ranking in the categories of Infectious Diseases, Miscellaneous Medicine, and Medical Microbiology as of 2023, reflecting its important role in disseminating impactful research. With many articles available through Open Access, it ensures wide accessibility to the latest discoveries and insights. Researchers can expect to find high-quality studies that address critical challenges in the control and prevention of infectious diseases, making this journal an essential resource for anyone engaging in this critical field.